THE VALUE OF AFP AND HCG HALF-LIVES IN PREDICTING THE EFFICACY OF COMBINATION CHEMOTHERAPY IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS

被引:0
|
作者
WILLEMSE, PHB
SLEIJFER, DT
KOOPS, HS
DEBRUIJN, HWA
OOSTERHUIS, JW
BROUWERS, TM
OCKHUIZEN, T
MARRINK, J
机构
[1] STATE UNIV GRONINGEN HOSP, OBSTET & GYNAECOL LAB, GRONINGEN, NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP, IMMUNOCHEM LAB, GRONINGEN, NETHERLANDS
[3] STATE UNIV GRONINGEN HOSP, DEPT SURG ONCOL, GRONINGEN, NETHERLANDS
[4] STATE UNIV GRONINGEN HOSP, DEPT PATHOL, GRONINGEN, NETHERLANDS
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:129 / 134
页数:6
相关论文
共 50 条
  • [21] Non-seminomatous germ-cell tumors: therapy and follow-up
    Cathomas, R.
    ONKOLOGIE, 2012, 35 : 105 - 105
  • [22] THE MANAGEMENT OF EARLY STAGE NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - EDINBURGH 1970-1981
    DUNCAN, W
    MUNRO, AJ
    BRITISH JOURNAL OF UROLOGY, 1985, 57 (05): : 560 - 566
  • [23] The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors
    Bokemeyer, C
    Harstrick, A
    Beyer, J
    Metzner, B
    Rüther, U
    Hartmann, JT
    Holstein, K
    Derig, HG
    De Wit, R
    Casper, J
    Schöffski, P
    Kührer, I
    Illiger, HJ
    Kempf, B
    Reichle, A
    Föller, A
    Hossfeld, DK
    Fischer, JT
    Berdel, WE
    Gerhartz, HH
    Kirchner, H
    Pflüger, KH
    Ostermann, H
    Kanz, L
    Schmoll, HJ
    EUROCANCER 98, 1998, : 321 - 323
  • [24] Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors
    Madani, A
    Kemmer, K
    Sweeney, C
    Corless, C
    Ulbright, T
    Heinrich, M
    Einhorn, L
    ANNALS OF ONCOLOGY, 2003, 14 (06) : 873 - 880
  • [25] CHEMOTHERAPY OF NON-SEMINOMATOUS GERM-CELL TUMORS WITH A RELATIVE LOW-DOSE OF CIS-PLATINUM
    STEINKE, B
    HEIDEMANN, E
    OSTENDORF, P
    WILMS, K
    WALLER, HD
    ONKOLOGIE, 1983, 6 (03): : 144 - 147
  • [26] Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report)
    Sakalo, VS
    Korsh, OB
    Melnyk, A
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1996, 22 (3-5) : 263 - 265
  • [27] DRUG-THERAPY IN NON-SEMINOMATOUS GERM-CELL CANCERS OF TESTIS STAGE-A
    EKMAN, P
    EDSMYR, F
    ALMGARD, LE
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1978, : 31 - 31
  • [28] PROGNOSIS FOR PATHOLOGIC STAGE-1 NON-SEMINOMATOUS GERM-CELL TUMORS OF TESTIS MANAGED BY RETROPERITONEAL LYMPHADENECTOMY
    JOHNSON, DE
    BRACKEN, RB
    BLIGHT, EM
    JOURNAL OF UROLOGY, 1976, 116 (01): : 63 - 65
  • [29] COMPARISON OF 5 ONCODEVELOPMENTAL PROTEINS IN NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTES
    BRAUNSTEIN, GD
    THOMPSON, R
    MCINTIRE, KR
    CLINICAL RESEARCH, 1983, 31 (02): : A403 - A403
  • [30] FREQUENCY OF SERUM TUMOR-MARKER MONITORING IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMORS
    SECKL, MJ
    RUSTIN, GJS
    BAGSHAWE, KD
    BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 822 - 823